David M Ashley

14PUBLICATIONS
183CO-AUTHORS
BiomaterialsGene and molecular therapyInnate immunityPredictive and prognostic markersGenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 27, 2026
Anti-VEGF vascular remodeling drives germinal center B cell-rich tertiary lymphoid structures during antibody-toxin and anti-CD40 combination therapy in glioblastoma.

|Feb 12, 2026
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways.

Mark W Youngblood, Shashwat Tripathi, Hinda Najem

|Nov 21, 2025
Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration.

Andrea L Ludwig, Zachary P McKay, Griffin P Carter

|Aug 11, 2025
Resilience and Vulnerabilities of Tumor Cells under Purine Shortage Stress.

Jianpeng Yu, Chen Jin, Cheng Su

|Jun 12, 2025
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial.

Eric M Thompson, David M Ashley, Katayoun Ayasoufi

|May 09, 2025
Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics.

Avishay Spitzer, Kevin C Johnson, Masashi Nomura

Pageof 3

Frequent Collaborators

4 joint publications

Annick Desjardins

4 joint publications

Mustafa Khasraw

2 joint publications

David A Reardon

2 joint publications

Sarah L Cook